Vizient Inc. recently released its July 2017 Drug Price Forecast, which provides pharmacy leaders and health system executives with insights on pricing and practice changes throughout the pharmaceutical industry.
Read More »
Accorda Therapeutics receives Refusal to File letter for Inbrija
Research shows benefits of adhering to diabetes medication
Genentech's Actemra receives approval from FDA to treat CRS patients
BIO praises president's signature of FDA Reauthorization Act
ASPEN and Baxter collaborate on 'Smart PN' education